Intercept Pharmaceuticals, Inc. ICPT announced that it has formally notified the European Medicines Agency (“EMA”) of its decision to withdraw its marketing authorization application (MAA) for ...
As many market watchers expected, the FDA is calling for external input on Intercept Pharmaceuticals’ nonalcoholic steatohepatitis (NASH) candidate. But given a competitor’s recent clinical trial win, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback